Cefixime: Difference between revisions
Jump to navigation
Jump to search
m (Protected "Cefixime": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 20: | Line 20: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
'''Cefixime''' is an oral third generation [[cephalosporin]] [[antibiotic]]. It was sold under the trade name '''Suprax''' in the USA, until 2003 when it was taken off the market by drug manufacturer [[Wyeth]] after its [[patent]] expired. the oral suspension form of "Suprax" was re-launched by Lupin in the USA. Cefixime is still available in [[Canada]]. It is used to treat [[gonorrhea]]<ref name="McMillan-2007">{{cite journal | author=McMillan A, Young H. | title=The treatment of pharyngeal gonorrhoea with a single oral dose of cefixime. | journal=Int J STD AIDS | year=2007 | volume=18 | issue=4 | pages=253-4 | id=PMID 17509176}}</ref>, [[tonsilitis]]<ref name="Adam-1995">{{cite journal | author=Adam D, Hostalek U, Tröster K. | title=5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. | journal=Infection | year=1995 | volume=23 | issue=Suppl 2 | pages=S83-6 | id=PMID 8537138}}</ref>, and [[pharyngitis]]<ref name="Adam-1995" />. | '''Cefixime''' is an oral third generation [[cephalosporin]] [[antibiotic]]. It was sold under the trade name '''Suprax''' in the USA, until 2003 when it was taken off the market by drug manufacturer [[Wyeth]] after its [[patent]] expired. the oral suspension form of "Suprax" was re-launched by Lupin in the USA. Cefixime is still available in [[Canada]]. It is used to treat [[gonorrhea]]<ref name="McMillan-2007">{{cite journal | author=McMillan A, Young H. | title=The treatment of pharyngeal gonorrhoea with a single oral dose of cefixime. | journal=Int J STD AIDS | year=2007 | volume=18 | issue=4 | pages=253-4 | id=PMID 17509176}}</ref>, [[tonsilitis]]<ref name="Adam-1995">{{cite journal | author=Adam D, Hostalek U, Tröster K. | title=5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. | journal=Infection | year=1995 | volume=23 | issue=Suppl 2 | pages=S83-6 | id=PMID 8537138}}</ref>, and [[pharyngitis]]<ref name="Adam-1995" />. | ||
| Line 37: | Line 37: | ||
[[Category:Thiazoles]] | [[Category:Thiazoles]] | ||
[[pl:Cefiksym]] | [[pl:Cefiksym]] | ||
Revision as of 23:36, 8 August 2012
| File:Cefixime.png | |
| Clinical data | |
|---|---|
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code | |
| Pharmacokinetic data | |
| Bioavailability | 40% to 50% |
| Protein binding | Approximately 60% |
| Elimination half-life | Variable Average 3 to 4 hours |
| Excretion | Renal and biliary |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C16H15N5O7S2 |
| Molar mass | 453.452 g/mol |
|
WikiDoc Resources for Cefixime |
|
Articles |
|---|
|
Most recent articles on Cefixime |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Cefixime at Clinical Trials.gov Clinical Trials on Cefixime at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Cefixime
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Cefixime Risk calculators and risk factors for Cefixime
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Cefixime |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Cefixime is an oral third generation cephalosporin antibiotic. It was sold under the trade name Suprax in the USA, until 2003 when it was taken off the market by drug manufacturer Wyeth after its patent expired. the oral suspension form of "Suprax" was re-launched by Lupin in the USA. Cefixime is still available in Canada. It is used to treat gonorrhea[1], tonsilitis[2], and pharyngitis[2].
References
- ↑ McMillan A, Young H. (2007). "The treatment of pharyngeal gonorrhoea with a single oral dose of cefixime". Int J STD AIDS. 18 (4): 253–4. PMID 17509176.
- ↑ 2.0 2.1 Adam D, Hostalek U, Tröster K. (1995). "5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy". Infection. 23 (Suppl 2): S83–6. PMID 8537138.
External links
- Suprax Online - Information about cefixime.
- Notice to Readers: Discontinuation of Cefixime Tablets --- United States - A FDA report alerting physicians about the discontinuation of cefixime.
Categories:
- Pages with script errors
- CS1 maint: Multiple names: authors list
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Cephalosporin antibiotics
- Thiazoles